THERAPEUTIC POTENTIAL OF CANNABINOIDS

被引:6
作者
BATEMAN, DN
RAWLINS, MD
机构
关键词
D O I
10.1136/bmj.284.6324.1211-a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1211 / 1212
页数:2
相关论文
共 19 条
[1]  
COLLS BM, 1980, NEW ZEAL MED J, V91, P449
[2]  
COLLS BM, 1980, LANCET, V1, P1187
[3]   NABILONE - AN EFFECTIVE ANTI-EMETIC IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].
EINHORN, LH ;
NAGY, C ;
FURNAS, B ;
WILLIAMS, SD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S64-S69
[4]   AMELIORATION OF CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING BY DELTA-9-TETRAHYDROCANNABINOL [J].
EKERT, H ;
WATERS, KD ;
JURK, IH ;
MOBILIA, J ;
LOUGHNAN, P .
MEDICAL JOURNAL OF AUSTRALIA, 1979, 2 (12) :657-659
[5]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC FOR PATIENTS RECEIVING CANCER-CHEMOTHERAPY - COMPARISON WITH PROCHLORPERAZINE AND A PLACEBO [J].
FRYTAK, S ;
MOERTEL, CG ;
OFALLON, JR ;
RUBIN, J ;
CREAGAN, ET ;
OCONNELL, MJ ;
SCHUTT, AJ ;
SCHWARTAU, NW .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :825-830
[6]  
GARB S, 1980, IRCS MED SCI-BIOCHEM, V8, P203
[7]   ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].
GRALLA, RJ ;
ITRI, LM ;
PISKO, SE ;
SQUILLANTE, AE ;
KELSEN, DP ;
BRAUN, DW ;
BORDIN, LA ;
BRAUN, TJ ;
YOUNG, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909
[8]   BRONCHODILATOR EFFECT OF DELTA-1-TETRAHYDROCANNABINOL [J].
HARTLEY, JPR ;
NOGRADY, SG ;
SEATON, A ;
GRAHAM, JDP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (06) :523-525
[9]   SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTI-EMETIC IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].
HERMAN, TS ;
EINHORN, LH ;
JONES, SE ;
NAGY, C ;
CHESTER, AB ;
DEAN, JC ;
FURNAS, B ;
WILLIAMS, SD ;
LEIGH, SA ;
DORR, RT ;
MOON, TE .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (23) :1295-1297
[10]   EVALUATION OF INTRAMUSCULAR LEVONANTRADOL AND PLACEBO IN ACUTE POSTOPERATIVE PAIN [J].
JAIN, AK ;
RYAN, JR ;
MCMAHON, FG ;
SMITH, G .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S320-S326